Cost comparison of psoriasis treatments

Journal of Cutaneous Medicine and Surgery

Volumn 13, Issue 6, 2009, Pages 303-307

  Mikhael, Dalia ^a,b   Babcock, Kelly ^a,b   DesGroseilliers, Jean Pierre ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b University of Ottawa   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; IMMUNOSUPPRESSIVE AGENT;

AMBULATORY CARE; ARTICLE; CANADA; COMPARATIVE STUDY; COST; DIAGNOSIS, MEASUREMENT AND ANALYSIS; ECONOMICS; FEMALE; HOSPITALIZATION; HUMAN; MALE; PHOTOTHERAPY; PSORIASIS;

COSTS AND COST ANALYSIS; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; OFFICE VISITS; ONTARIO; PHOTOTHERAPY; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 77649228671     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2009.08088     Document Type: Article

References (6)

1. Canadian Dermatology Associatiion. Psoriasis. Available at: www.dermatology.ca (accessed March 16, 2008).
2. Wolverton SE. Comprehensive dermatologic drug therapy. China: Saunders Elsevier; 2007.
3. Simpson JF, Yelverton CB, Balkrishnan R, et al. Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis. Managed Care Interface 2006;19:39-43.
4. Yelverton CB, Kulkarni AS, Balkrishnan R, et al. At home UVB therapy vs. systemic therapies. Skin Aging 2005;13:50-2.
5. Pearce DJ, Thomas CG, Fleischer AB Jr, et al. The cost of psoriasis therapies: considerations for therapy selection. Dermatol Nurs 2004;16:421-32.
6. Haykal KA, DesGroseilliers JP. Are narrow-band ultraviolet B home units a viable option for continuous or maintenance therapy of photoresponsive diseases? J Cutan Med Surg 2006;10:234-40.